• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagnostics (Basel) . Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVI

tetano

Editor, Senior Moderator
Diagnostics (Basel)


. 2022 Jan 28;12(2):339.
doi: 10.3390/diagnostics12020339.
Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19)


Hiroyoshi Yamada[SUP] 1 2 [/SUP], Masaki Okamoto[SUP] 1 2 [/SUP], Yoji Nagasaki[SUP] 3 [/SUP], Suzuyo Yoshio[SUP] 4 [/SUP], Takashi Nouno[SUP] 1 2 [/SUP], Chiyo Yano[SUP] 1 2 [/SUP], Tomohiro Tanaka[SUP] 1 2 [/SUP], Fumi Watanabe[SUP] 1 [/SUP], Natsuko Shibata[SUP] 1 [/SUP], Yoko Arimizu[SUP] 3 [/SUP], Yukako Fukamachi[SUP] 3 [/SUP], Yoshiaki Zaizen[SUP] 2 [/SUP], Naoki Hamada[SUP] 5 [/SUP], Atsushi Kawaguchi[SUP] 6 [/SUP], Tomoaki Hoshino[SUP] 2 [/SUP], Shigeki Morita[SUP] 7 [/SUP]



Affiliations

Abstract

Certain biomarkers predict death due to acute respiratory distress syndrome in COVID-19 patients. We retrospectively analyzed biomarkers associated with time to mechanical ventilation for respiratory failure due to COVID-19 (time-to-mechanical ventilation) in 135 consecutive patients in our hospital. We analyzed biomarkers that were elevated immediately (at admission) and later (3 days after admission) using Cox proportional hazards regression analysis. Independent biomarkers of time-to-mechanical ventilation were high C-reactive protein (CRP), interleukin (IL)-6, and Krebs von den Lungen-6 (KL-6) concentrations at admission and elevated CRP, high-mobility group box-1 protein (HMGB-1), and d-dimer levels and low platelets 3 days after admission. Receiver operating characteristic analysis for detecting the association between independent biomarkers associated with time-to-event in multivariate analyses and the start of mechanical ventilation revealed that these biomarkers had area under the curve values higher than 0.700. The present study suggests that CRP was the only biomarker associated with time-to-mechanical ventilation both at admission and 3 days after admission. Moreover, IL-6 (an inflammatory cytokine), HMGB-1 (a late inflammatory mediator), and KL-6 (reflecting injury and/or remodeling of type II pneumocytes) were associated with outcomes in COVID-19 as reported previously. In conclusion, increased CRP, IL-6, KL-6, HMGB-1, and d-dimer levels and decreased platelet counts were associated with the start of mechanical ventilation due to COVID-19.

Keywords: Krebs von den Lungen-6; biomarker; coronavirus disease; high-mobility group box-1 protein; interleukin-6.
 
Back
Top Bottom